Clinical parameters | |
---|---|
mean (range) | |
Age at diagnosis; in years | 74 (56–88) |
Follow-up time; in months | 35 (2–113) |
Progression-free interval; in months | 14 (0–96) |
N (%) | |
FIGO 2009 stage | |
IA | 5 (14%) |
IB | 10 (27%) |
II | 3 (8%) |
IIIA | 2 (5%) |
IIIC | 10 (27%) |
IVA | 1 (3%) |
IVB | 6 (16%) |
Level of surgical cytoreduction a | |
Complete | 26 (72%) |
Residual disease | 10 (28%) |
Adjuvant chemotherapy | |
Yes | 23 (62%) |
No | 14 (38%) |